Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Childhood Caries Prevention Follow-up
ACTRN12609000330246Phase 4Completed
- Sponsor
- Metro South Health Oral Health
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluoride toothpaste, casein phosphopeptide-amorphous calcium phosphate and chlorhexidine in early childhood caries (ECC) (3 arms), sponsored by Metro South Health Oral Health. Started Sep 2009; status: completed.
02
Drugs
fluoride toothpastecasein phosphopeptide-amorphous calcium phosphatechlorhexidine
03
Conditions
early childhood caries (ECC)
Beyond the preview
Go deeper on ACTRN12609000330246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000330246.